An FDA committee voted on July 24, 2026 to recommend making certain peptides available through compounding pharmacies despite FDA staff opposition. Critics noted that some committee members have financial ties to peptide producers, raising conflict-of-interest concerns.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.
this outlet adds: ignored, staff, advice, voting, recommend, made, available, many
this outlet adds: time, article, 2026, medical, freedom, evidence, based, medicine
this outlet adds: flip, fsveka, decisions, appear, arise, primarily, votes, members